TREM2 risk variants and associated endophenotypes in alzheimer’s disease

This study shows that while carriers of TREM2 risk variants cannot be distinguished based on clinical presentation at baseline compared to non-carriers, they do exhibit a faster global cognitive decline. Variant-specific analyses indicate that especially R47H and T96K carriers drive this association. These results highlight the importance of considering variant-specific effects for understanding the role of TREM2 biology in AD. The rich phenotype information can inform clinical stage drug development.

Authors

Institutions

Publication Details

Journal
Alzheimer s Research & Therapy
Published
2025-03-06
DOI
https://doi.org/10.1186/s13195-025-01700-2
Citations
12
Primary Topic
Inflammation biomarkers and pathways
Type
article
Field-Weighted Citation Impact
9.57
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

TREM2 risk variants and associated endophenotypes in alzheimer’s disease

Lisa Vermunt, Marc Hulsman, Rik Ossenkoppele, Betty Marije Tijms et al.
12 citations
Alzheimer s Research & Therapy
Inflammation biomarkers and pathways
9.57
article

TREM2 risk variants and associated endophenotypes in alzheimer’s disease

Lisa Vermunt, Marc Hulsman, Rik Ossenkoppele, Betty Marije Tijms, Wiesje M. van der Flier, Emma M. Coomans, Elsmarieke van de Giessen, Henne Holstege, Vikram Venkatraghavan, Frederik Barkhof, Alida A. Gouw, Janna I.R. Dijkstra, Christa M. de Geus, Sietske A.M. Sikkes, Charlotte Elisabeth Teunissen, Everard G.B. Vijverberg, Willem de Haan, Yolande A.L. Pijnenburg, Sven J. van der Lee, Georgii Ozhegov
article en
12 citations

Abstract

This study shows that while carriers of TREM2 risk variants cannot be distinguished based on clinical presentation at baseline compared to non-carriers, they do exhibit a faster global cognitive decline. Variant-specific analyses indicate that especially R47H and T96K carriers drive this association. These results highlight the importance of considering variant-specific effects for understanding the role of TREM2 biology in AD. The rich phenotype information can inform clinical stage drug development.

Alzheimer s Research & TherapyVol. 17(1)
Lund University (SE), Amsterdam Neuroscience (NL), GGD Amsterdam (NL), National Hospital for Neurology and Neurosurgery (GB), Amsterdam University Medical Centers (NL), University College London (GB), Vrije Universiteit Amsterdam (NL), Amsterdam UMC Location Vrije Universiteit Amsterdam (NL), Delft University of Technology (NL)
Good health and well-being
Openalex Percentile: Top 2%
Inflammation biomarkers and pathways
9.57
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.